Biology-based materials for a better world
Zymergen was founded in 2013 in Emeryville, California as a biomanufacturing company using AI, machine learning, robotics, and synthetic biology to engineer microbes for the production of novel materials and chemicals. The company raised over $900 million before going public in April 2021. Ginkgo Bioworks acquired Zymergen in October 2022 for approximately $300 million, integrating its software, data science tools, and automation capabilities.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountApr 2021
Sep 2020
Dec 2018
Oct 2016
Jun 2015
Jun 2015
Jun 2013
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Anduril Industries is a defense technology company with a mission to transform US and allied mili...
